Medication info

Xone A Tablet 5/160/20 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›160mg / 1 tabletAtorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Pale pink oval film-coated tablet
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202005385 · Approved 2020.07.24 · Insurance code 640007690

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular diseases (such as myocardial infarction)
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. If possible, it is recommended that you take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking the amlodipine/valsartan combination together with atorvastatin as a separate product may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before starting the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended starting dose is atorvastatin 10 mg once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular diseases (such as myocardial infarction)

  • Essential hypertension
  • hypercholesterolemia
  • dyslipidemia
  • primary dysbetalipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not well controlled with amlodipine and valsartan combination therapy. Additionally, atorvastatin is used in various patient groups to reduce the risk of cardiovascular diseases, such as helping to reduce the risk of myocardial infarction and stroke. Atorvastatin is also effective in controlling cholesterol and triglyceride levels in patients with dyslipidemia. This medication is suitable for patients who need to manage both hypertension and cardiovascular disease risk.

How to take

Adult dose

Take 1 tablet once daily with water. If possible, it is recommended that you take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking the amlodipine/valsartan combination together with atorvastatin as a separate product may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before starting the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended starting dose is atorvastatin 10 mg once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy and should be discontinued immediately upon confirmation of pregnancy. If muscle-related issues are suspected or if muscle enzyme levels rise significantly, the use of this medication should be stopped, as there is a risk of serious muscle damage leading to renal failure, requiring caution. This medication should not be administered to patients with certain diseases or conditions, such as those with severely impaired liver or kidney function, pregnant or breastfeeding women, or individuals with specific allergies. Patients with fluid or sodium depletion, hyperkalemia, renal artery stenosis, or those with kidney transplants should use this medication cautiously, with close monitoring before and during administration. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. This medication can affect liver function, so patients with a history of liver disease should consult a doctor before taking it and undergo regular liver function tests. If symptoms of muscle pain, weakness, or fever occur, they should contact a doctor immediately, and discontinuation should occur if abnormalities are found in muscle enzyme testing. There may be interactions with other medications taken with this medication, so patients must inform their doctor or pharmacist of any other medications they are currently taking. Particularly, when taken with potassium-sparing diuretics or potassium supplements, potassium levels may dangerously rise, requiring periodic blood tests. This medication is not recommended for breastfeeding women, and atorvastatin is contraindicated during breastfeeding. Women of childbearing age should use appropriate contraception while taking this medication, and should consult their doctor if planning to become pregnant. While taking this medication, regular examinations are needed for symptoms of abnormal liver function, muscle issues, or changes in blood pressure. Anyone experiencing abnormal symptoms while on medication should consult medical personnel immediately.

Side effects

  • Dry eye
  • nausea
  • headache
  • nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • dizziness
  • drowsiness
Show 206 more
  • positional dizziness
  • paresthesia
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pharyngeal and laryngeal pain
  • diarrhea
  • abdominal pain
  • constipation
  • thirst
  • rash
  • erythema
  • sweating
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle cramps
  • lethargy
  • polyuria
  • polydipsia
  • erectile dysfunction
  • edema
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • weakness
  • facial flushing
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • dysgeusia
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • angioedema
  • vesicular dermatitis
  • myalgia
  • renal failure
  • renal damage
  • increased serum creatinine
  • weakness
  • fatigue
  • chest pain
  • fatigue
  • fever
  • pharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • epistaxis
  • nightmares
  • perceptual disturbances
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • muscle spasms
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorder
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • bile duct obstruction
  • liver failure
  • blurred vision
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • angioedema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • alopecia
  • purpura
  • skin depigmentation
  • angioedema
  • urticaria
  • Stevens-Johnson syndrome
  • thrombocytopenia
  • increased serum potassium
  • renal failure
  • renal damage
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection
  • abnormal liver function
  • jaundice
  • fulminant hepatitis
  • hepatitis
  • vasculitis
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • alopecia
  • purpura
  • skin depigmentation
  • angioedema
  • urticaria
  • Stevens-Johnson syndrome
  • thrombocytopenia
  • increased serum potassium
  • renal failure
  • renal damage
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection
  • abnormal liver function
  • jaundice
  • fulminant hepatitis
  • hepatitis
  • vasculitis
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • alopecia
  • purpura
  • skin depigmentation
  • angioedema
  • urticaria
  • Stevens-Johnson syndrome
  • thrombocytopenia
  • increased serum potassium
  • renal failure
  • renal damage
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection
  • abnormal liver function
  • jaundice
  • fulminant hepatitis
  • hepatitis
  • vasculitis
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • alopecia
  • purpura
  • skin depigmentation
  • angioedema
  • urticaria
  • Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Moreover, it is advisable to keep the medication at room temperature between 1 Celsius and 30 Celsius, away from extreme heat or cold.

Appearance and packaging

Appearance

Pale pink oval film-coated tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.